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Aortic arch pathologies –
incidence and natural history
Introduction
Aortic arch pathologies are uncommon
and often pose signiﬁcant challenges
to surgical or endovascular treatment.
Many of the patients were either asymp-
tomatic or otherwise had catastrophic
life-threatening events. The true inci-
dence and natural history of aortic arch
diseases remain relatively unknown and
treatment is often based on single center
case series or large registries and there
is reporting bias. Selection bias: patients
selected for surgical treatment may be
limited by anatomy and presentation.
Poor outcome may not have been re-
ported. Conditions aﬀecting the aortic
arch relevant to the vascular surgeon
include degenerative aneurysms and the
acute aortic syndromes (e.g. penetrating
ulcers, intramural hematoma and aortic
dissections).
Aortic arch aneurysms
Degenerative aneurysms of the aortic
arch are often asymptomatic. With the
increase in usage of diagnostic imag-
ing and aging populations, aortic arch
aneurysms have been increasingly di-
agnosed. In a study of 590 consecutive
patients undergoing surgery for tho-
racic aortic diseases, 78% of whom had
aneurysms, it was suggested that thoracic
aortic pathology may be more common
in patients with anatomical arch anoma-
lies, in particular bovine arches and the
patients are slightly younger (average age
of 58.6 years for patients with aortic arch
anomalies, compared to 62.4 years for
those without arch anomalies) [1]. The
increase in size of aortic arch aneurysms
is an indolent process, with a reported
mean annual growth rate of 0.07–0.2 cm/
year [2]. Risk factors include age, fe-
male gender, chronic obstructive airway
disease, hypertension, aortic diameter
and a family history of aneurysms [3,
4]. There has been no prior study on the
expansion rate or risk of rupture of true
aneurysms speciﬁc to the aortic arch.
The Yale University study [3] reported
a growth rate of 1.2 mm per year in
a mixed cohort with smaller aneurysms.
A subsequent study from the same in-
stitution on 721 patients with thoracic
pathology again reported an aortic ex-
pansionrateof1mmperyearandayearly
rupture risk of 6.9 % in aneurysms ex-
ceeding 6 cm [5]. Prospective studies on
descending thoracic and thoracoabdom-
inal aneurysms reported a rupture risk of
23% in 114 patients [4]. Similar earlier
studies also reported a high incidence
of rupture of up to 47% in thoracic
aneurysms treated medically and that
the 5-year survival was only 21% in non-
surgery groups and 50% in all patients
[6]. The yearly risk of aneurysm rupture
increases generally with aneurysm size
[5] and surgical intervention is therefore
recommended for thoracic aneurysms
that exceed a maximum diameter of
5.5–6.5 cm. The authors have recently
conducted a study [7] on the natural his-
tory on 45 patients with isolated aortic
arch aneurysms monitored with serial
computed tomography (CT) scanning,
excluding thoracoabdominal aneurysms
and dissections. In a mean follow-up
of 37 months the arch aneurysms were
found to exhibit a tendency to linear
growth with an average rate of 2.5 mm
per year. Expansion rates were found
to be associated with an aneurysm size
>6.5cmandalsowithhyperlipidemia [7].
While smaller aneurysms not included
in this study may not be expanding at
a similar rate, it is also possible that aortic
arch aneurysm expansion is faster com-
pared to rates reported for descending
thoracic aneurysms. During surveil-
lance in this study 22% of aneurysms
ruptured with an 80% mortality. This
rate of rupture is comparable to the
23 % rupture rate reported in previous
natural history studies on descending
and thoracoabdominal aneurysms [4].
On multivariate analysis of risk factors,
only the aneurysm expansion rate of
>5.5 mm per year was identiﬁed as an
independent risk factor of rupture (67 %
vs. 8 %, odds ratio of 1.43). A phase
of rapid growth seems to occur before
rupture and growth rate is the single
most important predictor of rupture. In
this series of patients more than one
in ﬁve aneurysms ruptured in a mean
follow-up period of 3 years, reinforcing
the substantial risk of aneurysms in this
location, where the arch is subjected to
the highest blood pressure and hemo-
dynamic stress. The maximum diameter
of the aortic arch remains an important
determinant of rupture.
Acute aortic syndromes
Acute aortic syndromes comprise acute
aortic dissections, intramural hematoma
(IMH) and penetrating aortic ulcers
(PAU). They can aﬀect any part of
the thoracic aorta, including the aortic
arch. Penetrating ulcers and intramural
hematomas are often considered variants
of a true aortic dissection. It is estimated
that one in eight patients with acute
aortic dissection has an IMH or PAU.
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Penetrating ulcers
ThePAUs are focal disruptions of the aor-
tic intima breaching the internal elastic
lamina to involve the media. They usu-
ally aﬀect older patients, in atheroscle-
rotic or diseased, dilated aortas and can
be multiple. Other known risk factors
for PAU include hypertension, smok-
ing, coronaryarterydiseases, chronicob-
structive airways disease and renal insuf-
ﬁciency. They can progress or be associ-
atedwith intramuralhematomas, rupture
ordevelop into anacute aortic dissection.
Stanson et al. reviewed 684 aortograms
and found16patientswithPAUin thede-
scending thoracic aorta, giving an overall
incidence of 2.3 % [8]. In a study using
transesophageal echocardiograms in 194
patients for thoracic aortic disease, 12
(6.2 %) PAUs were found, 25% of which
occurred in the aortic arch [9]. Again
the true incidence of PAU, particularly
in the arch, remain unknown. With the
increaseduseof imagingmethods, occur-
rences as high as 11%have been reported
in patients presenting with acute aortic
syndromesbutotherstudieswerenotable
to conﬁrm this rising trend. A study on
incidental ﬁndings of PAU in cardiac CT
scans showed only 2 penetrating ulcers
in 966 scans [10].
The natural history of PAU is also de-
bated. The main complications are rup-
ture, aortic dissection and aneurysm for-
mation. Ithasbeensuggested thatallPAU
should be viewed as potentially danger-
ous and may lead to rupture [11]. If
left untreated 30% may enlarge to form
a saccular aneurysm [12]. Supporters
of this theory regarded PAU as progres-
sive and any symptomatic ulcers should
be treated by surgery or endovascular
means as conservative therapy failed in
up to 50% of patients with PAU in the
descending thoracic aorta [8, 13]. A PAU
can be a precursor of aortic dissection.
The Yale group found that 7.6 % of 198
patientswithaorticdissectionshadaPAU
and advocated aggressive repair in symp-
tomatic patients. Of their patients 40%
of those treated with conservative means
had aortic ruptures and needed emer-
gency interventions [14]. Later the same
investigators reasserted their notion by
reporting an early rupture rate of 38%
and hospital mortality rate of 15% in
26 patients with PAU [15]. Similarly,
a Stanford University group of investi-
gators treated 33 patients with PAU in
65 patients presenting with intramural
hematoma whereby 48% of those pro-
gressed and conservative treatment re-
sulted in a 10% mortality [16]. These
reports suggested that those PAU asso-
ciated with acute dissections or intra-
mural hematoma tend to give a poorer
prognosis. In symptomatic patients it
is estimated that 25% may progress to
pseudoaneurysm formation and up to
one third result in ruptures [17]; how-
ever, others have shown that the natu-
ral history of PAU is more benign and
a more conservative management may
be adopted especially in asymptomatic
patients. In a radiology study using CT
scans on 33 ulcers, 64% of lesions re-
mained stable over a mean follow-up of
18 months. Out of an initial 56 lesions,
66% were clinically stable. The authors
concluded that most PAUs are asymp-
tomatic and do not enlarge, while for the
one third that progress the result is mild
interval aortic enlargement (less than 1.5
times normal aorta diameter) [18]. No
CT features were identiﬁed to predict
progression. Cho et al. reviewed 105
PAU in the descending thoracic aorta
and aortic arch, 85 of which were associ-
atedwith intramural hematomaand75 %
were symptomatic. About one third of
patients were treated with surgery with
a mortality of 21%. A total of 76 (72%)
of patients were treated medically with
3 deaths within 30 days. Generally in
the vascular surgery community medical
treatment of dissection is understood to
be conservative treatment with medica-
tions on blood pressure control. Rupture
at presentation predicted failure of med-
ical therapy. They concluded that even
in the acute setting many PAU can be
managed non-operatively [19].
Intramural hematoma
Caused by rupture of the vasa vasorum
with bleeding into the aortic media, in-
tramural hematoma (IMH) can be found
in about 5–20% of patients with acute
aortic syndrome. This is a disease of the
elderly and typically seen in patients over
70 years old. Risk factors include age,
hypertension, atherosclerosis and IMH
is believed to be a result of diﬀerential
rigidity of medial and shear stress. The
prevalence of IMH was reported to be
3.5 % from the International Registry of
Acute Aortic Dissection (IRAD) registry
[20]. There were discrepancies in other
countries and the incidence of IMH has
been reported to be higher in Asia: 44%
in Japan [21] and 28% in Korea [22]. As
a rule approximately one third of IMH
will remain, one third will resolve and
one third will progress to full aortic dis-
section.
If the IMH involves the aortic arch
and ascending aorta the complication
andmortality rates are highwithmedical
managementapproaching thatofa typeA
aortic dissection, whereas type B IMH
seem to be more benign and most can
be treated medically. The IRAD registry
reported 107 patients with type B IMH
where 88% were treated medically with
a hospital mortality of 7%. During fol-
low-up the mortality was 7% and no ad-
verse events were observed [23]. Symp-
tomatic IMH has a higher incidence of
rupture at presentation, up to 38% [17].
In a meta-analysis of 143 reported cases
IMH was associated with a mortality of
21% [24]. Although there was no dif-
ference in the overall mortality between
Stanford type A and B IMH, patients
with type A IMH fared worse on medi-
cal treatment compared to surgery (36 %
vs 14% mortality) and also compared to
type B IMH treated medically (14%). In
type B IMH medical and surgical out-
comes were similar. The IRAD data also
conﬁrmed a higher mortality if the IMH
involved the ascending aorta (39 %)com-
pared with the descending aorta (8.3 %)
[25]. Mortality is also higher if IMH is
associated with penetrating ulcers. The
natural history of IMH and rates of pro-
gression are not well known due to the
diﬃculty in diagnosis and follow-up bias.
AnIMHmayrupture, stabilize, regressor
progress to dissection or aneurysm for-
mation. Nienaber et al. reported a rate
of progression of IMH to overt dissec-
tion, rupture or tamponade in 8 out of
25 patients (32%) within 24–72 h, indi-
cating the need for urgent intervention
[26]. The progression of type A IMH to
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dissection in the literature ranged from
15% to 85% [27].
A Japanese registry compared 30 pa-
tients with type A IMH and 101 patients
with acute type A dissection where all
patients with type A IMH were initially
treated medically. Failure of medical
treatment and progression into dissec-
tion occurred in 43% of patients. The
overall hospital mortality of IMH (7 %)
was signiﬁcantly lower than the dissec-
tion group (24%) and the long-term sur-
vival rates of IMHwere also signiﬁcantly
better at 5 years (90% vs 62%), indicat-
ing that type A IMH have a better long-
term prognosis than type A dissections
[28].
Several risk factors have been pro-
posed to predict progression of type A
IMH to dissection. A dilated aorta and
an ascending aorta diameter >5 cm were
shown to be signiﬁcant predictors of pro-
gression [29]. Other factors included the
presenceofaPAU,pleural andpericardial
eﬀusion, aortic regurgitation, persistent
pai, and mediastinal hematoma [27]. In
a CT analysis of 29 patients with IMH,
Choi et al. identiﬁed type A, the maxi-
mum thickness of the IMHand compres-
sion of the true lumen to be indicative
of active bleeding and increased risk of
progression [30].
Aortic dissection
There are many reports on the incidence
of acute aortic dissections but the true
incidence again is unknown due to the
possibility of atypical presentations, un-
diagnosed cases and sudden death. The
IRAD reported that up to 30% were
typeB(not involvingtheascendingaorta)
[31]. Population studies indicated that
aortic dissection occurs in about 2–4 per
100,000 persons per year [32, 33]. The
prevalence of aortic dissection ranged
from 0.2% to 0.8 % in autopsy studies
[34]. There is some evidence to suggest
that the incidence of aortic dissection is
on the increase, up to 14 per 100,000 per-
sons per year [35]. The incidence of aor-
tic dissection after major cardiac surgery
was estimated at 0.03–0.1 %, with aortic
valve replacement carrying the highest
risk.
In the northern Italy Emilia-Romagna
Regional Database of hospital admis-
sions, between 2000 and 2008 there were
1500 patients with acute aortic dissec-
tions, of whom 41% were type A, 58%
type B and 10% were complicated. They
also reported an overall incidence of
4.7/100,000, with a male preponderance
of 6.7 % vs 2.9% females [34]. Notably
almost 20% of patients were 80 years
of age or older. The overall in-hospital
mortality was 27.7 %, 21.1 %, 26.9 %
and 33%, respectively for surgically
treated type A, thoracic endovascular
aortic repair (TEVAR) treated com-
plicated type B and medically treated
patients. Overall survival was at 62.2 %,
58.7% and 55.8 % at 1, 2 and 3 years,
respectively. Interestingly the authors
found the annual incidence increased
signiﬁcantly with age. On the other
hand, a Sino-RAD registry established
in China in 2011 reported 1003 patients
with acute dissections [36]. The pa-
tients in this registry were signiﬁcantly
younger (mean age of 51.8 years), con-
sisting of more men (78%), with a lower
history of hypertension (59%). Despite
some criticism of selection bias and
inadequate follow-up this showed that
the true incidence of aortic dissection
varies between countries and is subject
to inﬂuence from socioeconomic status,
primary healthcare and referral systems.
The Interdisciplinary Expert Consensus
Document on type B dissection pooled
data from 63 studies and 6711 patients
and reported an early mortality of 6.4 %
with medical treatment and increased to
10.2%withTEVARand17.5 %withopen
surgery for acute dissections. In chronic
dissections of more than 6 weeks, a
5-year survival of 60–80% was reported.
Recurrence of symptoms, aneurysms
(>55 mm) or increase of aortic size
>4 mm are predictors of poor outcome
[37].
The fate of acute aortic dissections is
better understooddue to longer term fol-
low-up studies. Type B dissections are
considered mostly benign but death can
occur in acute stages from rupture and
malperfusion. The Yale experience con-
ﬁrms that uncomplicated type B dissec-
tions responded well to medical treat-
ment with an early survival of 91% and
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66% of patients had an uncomplicated
follow-up[16]. TheIRADdata from1996
to 2013 on 1034 patients with type B dis-
section suggested an overall mortality of
10.6 % and identiﬁed variables adversely
aﬀecting hospital mortality, such as age,
hypotension, periaortic hematoma, de-
scending diameter ≥5.5 cm, mesenteric
ischemia, acute renal failure and limb
ischemia to be signiﬁcant predictors of
hospital death [38]. Refractory pain is
also a predictor of in-hospital mortality
an increase the risk from 1.5% to 35.6 %
[39], aswell aspatientsolder than70years
[40]. Recently the IRAD investigators
put forward a hyperacute phase from on-
set of dissection to 24 h in addition to
acute (2–7 days), subacute (8–30 days)
and chronic phases. They observed that
the cumulative survival continued to sig-
niﬁcantly decline in all groups even up to
30 days, regardless of treatment modality
(94–99 %, 82–93%, 77–92%, 73–91%,
respectively) [41]. Open repair of com-
plicated acute type B dissection is associ-
ated with signiﬁcant morbidity andmor-
tality. A recent meta-analysis or contem-
porary series reported a pooled 30-day
mortality of 19 % and a total neurological
complication rate of 9.8 % [42]. While
medical management of uncomplicated
type B dissections can achieve a hospi-
tal mortality of 2.5–10% [37, 42–44], on
lon- term follow-up the false lumen may
continue toenlargeresulting inaneurysm
formation and is detrimental to survival.
In 2006 IRAD reported a 3-year mortal-
ity of type B dissection of almost 25%.
Complicated type B dissection deﬁned as
malperfusion, hypertensiondespitemed-
ical therapy and increase in perioarotic
hematoma and hemorrhagic pleural ef-
fusions were predictors of high hospital
mortality [37] as well as 3-year mortality
[45]. The long-term survival of surgical
and medically treated type B dissection
patients are similar, with 5-year survival
of 44–83% and 62–100% respectively,
with 5-year freedom from aortic event
rates of 59–68% and 45–77% respec-
tively[37]. InarecentstudyDurhametal.
described 198 patients with medically
managed acute type B dissections and re-
ported 58% failed medical management
at a mean follow-up of 4.2 years, includ-
ing 12% early failures within 2 weeks.
Freedom from intervention was 77% at
3 years and 74% at 6 years, with an in-
tervention-free survival of only 55% at
3yearsand41%at6years. Almost30%of
patients subsequently underwent aorta-
related interventionsand38 %died. They
concluded that in themajority of patients
with typeBdissectionsmedicinal therapy
will fail over time [44].
Progressive dilatation and subsequent
rupture of the false lumen are the com-
mon cause of long-term mortality. Risk
factors for aortic diameter growth in-
cluded male gender, an initial aortic di-
ameter >40 mm, a large false lumen and
a high blood pressure or pulse pressure.
There is increasing evidence that a persis-
tentlypatentor incompletely thrombosed
false lumen is associated with a poorer
prognosis [46, 47] but it is still uncertain
whether a partially thrombosed false lu-
men carries a greater risk of progression
than a completely patent false lumen.
Conclusion
Aortic arch aneurysms, penetrating ul-
cers, intramural hematoma and dissec-
tionsare increasinglydiagnosedwithbet-
ter imaging procedures. The complete
incidence and natural history is still rel-
atively unknown but there is increasing
evidence to make it possible to identify
patients at risk of disease progression and
ultimatelymortality. With the increase in
endovascular therapy, this information is
invaluable in guiding surgeons to the best
indications and timing for treatment.
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